Federal Supply Schedule V797D70168
Award Date 6/15/17
Last Date to Order 6/14/24
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- Richmond Pharmaceuticals, Inc., a woman-owned small business, was awarded a multiple award Federal Supply Schedule contract under Schedule 65 IB (Drugs, Pharmaceuticals, and Hematology Related Products) by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract, with a ceiling value of $39 million and a period of performance extending through February 14, 2029, enables VISN 12 to procure a comprehensive portfolio of pharmaceutical...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Ferndale Laboratories Inc. The contract provides pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs schedule (FSS-61-IB). With a potential value of $7,798,770 and a period of performance through March 2027, this multiple-award contract aims to procure various drugs, pharmaceuticals, and hematology-related products for VA...
- The key information from the provided federal contract IDV award is as follows: The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Federal Supply Schedule (FSS) contract to Stratus Pharmaceuticals Inc., a minority-owned, small disadvantaged, woman-owned business, to provide drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The contract has a ceiling value of $14,425,700 and a period of performance from October 1, 2023 through September...
- The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Vantive US Healthcare LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Federal Supply Schedule 65 IB. With a potential value of $25,000 and a period of performance through August 2024, this multiple-award schedule aims to ensure Veterans receive needed medical supplies and treatments. The...
- This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Leading Pharma LLC, provides for the procurement of pharmaceutical and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The single-award, indefinite delivery/indefinite quantity (IDIQ) contract has a period of performance through January 31, 2025 and a ceiling value of $225,000.00. The contract aims to meet the VA's requirements for a wide range of pharmaceuticals and...
- This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. The prime contractor is Q Biomed Inc. With a potential value of $225,000 and a period of performance through February 2026, the contract aims to deliver 65 I B drugs, pharmaceuticals, and hematology-related products to VA medical treatment facilities in the region. The...
- The federal contract IDV award is a multiple-award Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Department of Veterans Affairs Veterans Health Administration to RB Health US LLC, a division of RB Health (Us) LLC. The contract has a potential value of $27,440,000.00 and a period of performance from June 15, 2022, to June 14, 2027. The contract covers the provision of drugs, pharmaceuticals, and hematology-related products,...
- This Federal Supply Schedule contract, awarded by the U.S. Department of Veterans Affairs (VA), provides the VA with a multiple award vehicle for procuring pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The prime contractor, Reliable 1 Laboratories LLC, is a self-certified small disadvantaged business that was awarded this $1,365,780.00 contract with a period of performance through July 14, 2026. The contract aims to supply the VA with a wide range of pharmaceutical and...
- This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is a $200,000.00 interim agreement with Amarin Pharma, Inc. to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB. The contract has an ultimate completion date of August 30, 2024 and was awarded on March 5, 2024 without any set-aside requirements. The purpose of this multiple-award FSS contract is to...